Lidocaine Hci Injection, Solution
Product Images NDC 51662-1543

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Vial Labeling (51662 1543 1 Serialized Labeling)

Serialized Vial Labeling (51662 1543 1 Serialized Labeling)
Lidocaine HCl Injection, USP 2% (100 mg/5 mL or 20 mg/mL) in a 5 mL single-dose vial with a green cap. The label indicates preservative-free solution for infiltration and nerve block, including caudal and epidural use. Distributed by HF Acquisition Co., LLC, Mukilteo, WA. Rx only.*
FDA Label Image

Vial Label (51662 1543 1 Vial Label)

Vial Label (51662 1543 1 Vial Label)
Lidocaine HCl Injection, USP 20 mg/mL (2%) solution in a single-dose 5 mL vial by AuroMedics Pharmaceuticals. The sterile, nonpyrogenic injection is preservative-free and intended for infiltration and nerve block, including caudal and epidural use. Label states storage temperature and manufacturing information for AuroMedics Pharma LLC, E. Windsor, NJ.*
FDA Label Image

Case

Case
Label for LIDOCAINE HCI Injection, USP 2%, 20 mg/mL (100 mg/5 mL) in a 5 mL vial. The label indicates a case of 10 vials with NDC 51662-1543-3, lot number 123456, and expiration date 2039-01-01. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA 98275. The label includes storage instructions and dosing guidance for infiltration and nerve block use.*
FDA Label Image

Max Dosage (Max Dosage)

Max Dosage (Max Dosage)
A table titled 'Recommended Dosages' for Lidocaine Hydrochloride Injection (without epinephrine). It lists various medical procedures such as infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks with corresponding concentration percentages, volume in mL, and total dose in mg for each procedure or block site. A note at the bottom indicates epidural dose determination based on the number of dermatomes to be anesthetized.*
FDA Label Image

Pouch

Pouch
Label for LIDOCAINE HCI Injection, USP 2% (20 mg/mL) in a 5 mL vial. The label includes dosing strength (100 mg/5 mL), NDC 51642-1543-2, lot and expiration date fields, and storage instructions. It states use for infiltration and nerve block including caudal and epidural routes, preservative-free and sterile. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A data table titled 'Examples of Drugs Associated with Methemoglobinemia' listing drug classes and examples. Classes include nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs, with corresponding examples for each class.*
FDA Label Image

Rfid

Rfid
A small, clear plastic pouch with a white label containing a barcode and text including identifiers and a note to see the manufacturer's package insert. The label also states distribution by HF Acquisition Co LLC, located in Mukilteo, WA. No product name or dosage details are visible on the pouch label itself.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Lidocaine Hydrochloride (LIDOCAINE HCI), depicting its molecular arrangement including an aromatic ring substituted with two methyl groups, an amide linkage, and diethylamino groups associated with a hydrochloride (HCl) salt.*
FDA Label Image

Vial

Vial
Label for Lidocaine HCl Injection, USP, 20 mg/mL (2%) solution in a 5 mL single dose vial. Intended for infiltration and nerve block, including caudal and epidural use. Preservative-free, sterile, and nonpyrogenic. Manufactured in India for AuroMedics Pharma LLC, E. Windsor, NJ. Storage instructions and sterility warnings also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.